3C
PRAH

361 Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

361 Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-26,380
Closed -$2.4M – 370
2017
Q4 		$2.4M Sell
26,380
-513
-2% -$42.7K 0.6% 42
2017
Q3 		$2.05M Buy
+26,893
New +$2.03M 0.39% 135

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

361 Capital's PRAH Position: Q1 2018 in Review

361 Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2018, closing a stake of 26,380 shares — an estimated $2.4M sold.

361 Capital first reported a position in PRAH in Q3 2017 and held it in 2 quarters. The position peaked at $2.4M in Q4 2017. 278 funds tracked by Wall St. Rank hold PRAH as of Q1 2018.

  • 361 Capital reported no remaining PRA Health Sciences, Inc. position as of Q1 2018 after selling out during the quarter.
  • 361 Capital sold 26,380 PRA Health Sciences, Inc. shares in Q1 2018, an estimated $2.4M.
  • 361 Capital first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 2 quarters.
  • 361 Capital's PRA Health Sciences, Inc. position peaked at $2.4M in Q4 2017.
  • 278 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2018.

Based on 361 Capital's 13F filing for Q1 2018, filed 15 May 2018.